The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Targeting FGFR1-amplified lung squamous cell carcinoma with the selective pan-FGFR inhibitor BGJ398.
Lucia Nogova
Consultant or Advisory Role - Amgen; Roche
Honoraria - Amgen; Boehringer Ingelheim; Roche
Other Remuneration - Bayer; Lilly; Novartis; Pfizer
Lecia V. Sequist
Consultant or Advisory Role - AstraZeneca (U); Boehringer Ingelheim (U); Clovis (U); Merrimack Pharmaceuticals (U); Taiho Pharmaceutical (U)
Research Funding - Novartis
Philippe Alexandre Cassier
Consultant or Advisory Role - SERVIER
Honoraria - GlaxoSmithKline; Novartis
Research Funding - Novartis; Roche
Other Remuneration - Novartis; SERVIER
Manuel Hidalgo
No relevant relationships to disclose
Jean-Pierre Delord
Consultant or Advisory Role - Roche
Martin H. Schuler
Consultant or Advisory Role - Novartis
Research Funding - Novartis
Wan-Teck Lim
Honoraria - Novartis
D. Ross Camidge
Consultant or Advisory Role - Novartis
Reinhard Buettner
Honoraria - Lilly; Merck; Novartis; Pfizer; Qiaga; Roche
Lukas Carl Heukamp
Consultant or Advisory Role - Qiagen
Honoraria - Novartis; Roche
Research Funding - Novartis
Masyar Gardizi
No relevant relationships to disclose
Matthias Scheffler
No relevant relationships to disclose
Kato Kambartel
No relevant relationships to disclose
Francois Philippe Ringeisen
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
Suman Sen
Employment or Leadership Position - Novartis
Randi Isaacs
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
Maud Joannaert
Employment or Leadership Position - Novartis
Caroline Lefebvre
Employment or Leadership Position - Novartis
Juergen Wolf
Consultant or Advisory Role - Novartis
Honoraria - Novartis
Research Funding - Novartis